GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 2.384
AS - Asia 1.905
EU - Europa 909
SA - Sud America 337
AF - Africa 45
OC - Oceania 14
Totale 5.594
Nazione #
US - Stati Uniti d'America 2.278
SG - Singapore 790
IT - Italia 331
CN - Cina 304
BR - Brasile 265
VN - Vietnam 252
HK - Hong Kong 175
DE - Germania 159
GB - Regno Unito 73
IN - India 69
ID - Indonesia 65
JP - Giappone 64
BD - Bangladesh 49
FR - Francia 49
CA - Canada 47
MX - Messico 44
FI - Finlandia 42
NL - Olanda 42
PL - Polonia 42
RU - Federazione Russa 39
AR - Argentina 35
TR - Turchia 21
SE - Svezia 19
ES - Italia 18
ZA - Sudafrica 17
IQ - Iraq 16
AT - Austria 15
AU - Australia 14
AE - Emirati Arabi Uniti 12
UA - Ucraina 12
PK - Pakistan 11
CO - Colombia 9
EC - Ecuador 9
MY - Malesia 9
SA - Arabia Saudita 9
PH - Filippine 8
RO - Romania 8
CH - Svizzera 7
LT - Lituania 7
MA - Marocco 7
CZ - Repubblica Ceca 6
EG - Egitto 6
IE - Irlanda 6
TH - Thailandia 6
CR - Costa Rica 5
GR - Grecia 5
KR - Corea 5
VE - Venezuela 5
BE - Belgio 4
DK - Danimarca 4
HU - Ungheria 4
NG - Nigeria 4
UY - Uruguay 4
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KG - Kirghizistan 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 5.587
Città #
Singapore 494
Ashburn 417
San Jose 263
Santa Clara 171
Hong Kong 170
Chandler 127
Dallas 109
Beijing 95
New York 91
Ho Chi Minh City 87
Munich 85
Los Angeles 80
Council Bluffs 75
Tokyo 61
Hanoi 60
Milan 55
Jakarta 53
Fairfield 45
Warsaw 41
Lauterbourg 36
Shanghai 35
São Paulo 33
Ferrara 32
Houston 28
Mexico City 28
Bologna 26
Chicago 24
Addison 23
London 22
Rome 22
Bremen 21
Chennai 21
Princeton 21
Denver 20
Buffalo 19
Helsinki 18
Toronto 18
Hefei 17
Orem 17
The Dalles 17
Atlanta 16
Seattle 15
Cambridge 14
San Francisco 14
Turku 14
Phoenix 13
Amsterdam 12
Frankfurt am Main 12
Manchester 12
Montreal 12
Wilmington 12
Brooklyn 11
Modena 11
San Diego 11
Stockholm 10
Boston 9
Da Nang 9
Haiphong 9
Lappeenranta 9
New Delhi 9
Rio de Janeiro 9
Woodbridge 9
Falkenstein 8
Moscow 8
Poplar 8
Sydney 8
Ann Arbor 7
Boardman 7
Casalecchio Di Reno 7
Charlotte 7
Hải Dương 7
Kuala Lumpur 7
Mumbai 7
Naples 7
Ankara 6
Baghdad 6
Portland 6
Brasília 5
Buenos Aires 5
Columbus 5
Guarulhos 5
Hillsboro 5
Johannesburg 5
Nuremberg 5
Ottawa 5
Paris 5
Salt Lake City 5
Thái Nguyên 5
Vienna 5
Washington 5
Assago 4
Bangkok 4
Barnet 4
Brno 4
Bến Tre 4
Cairo 4
Calgary 4
Campinas 4
Casablanca 4
Dhaka 4
Totale 3.540
Nome #
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 207
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 196
A tool to predict survival in stage IV entero-pancreatic NEN 190
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 176
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 175
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 174
Functional hypothalamic and drug-induced amenorrhea: an overview 170
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 166
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 165
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 157
Acromegaly in the elderly patients 155
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 154
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 152
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 151
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 147
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 143
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 142
Bone health in adolescence 140
Craniopharyngioma and Eating Disorders 139
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 133
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 131
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 131
Long-term low-dose tolvaptan efficacy and safety in SIADH 130
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 129
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 128
Iperprolattinemia: vecchie e nuove insidie diagnostiche 127
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 124
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 123
Hypeprolactinemia: still an insidious diagnosis 122
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 115
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 112
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study 110
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 102
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 101
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 91
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 89
I livelli di colesterolo LDL sono associati alla secrezione insulinica 89
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 85
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 75
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 75
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 73
L’acromegalia nell’anziano 69
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 64
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) [Neuroendocrine Neoplasms prognostic markers] 57
Acromegalia: differenze di sesso e genere [Sex and gender differences in acromegaly] 43
Totale 5.727
Categoria #
all - tutte 31.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 826
Totale 31.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022166 9 4 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024314 12 24 15 10 16 47 13 27 26 15 15 94
2024/20251.264 43 50 96 52 138 138 60 54 217 118 162 136
2025/20263.545 348 131 319 418 554 226 408 229 298 407 177 30
Totale 5.727